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Background
Abnormal myocardial T2 signal has been described in a
minority of patients with hypertrophic cardiomyopathy
(HCM). This phenomenon has been associated with
arrhythmic outcomes and, given its more restrictive
prevalence versus late gadolinium enhancement (LGE),
offers a potentially useful biomarker for risk stratifica-
tion. To date, postulated mechanisms include active
tissue disease or unique collagen species, however, no
histopathologic correlation has been reported. In this
study, we examine the prevalence of T2 signal abnorm-
alities among patients with HCM and examine for asso-
ciations with other imaging-based markers of HCM
phenotypic expression. Incrementally, we provide
comprehensive histopathologic correlation of a patient
undergoing cardiac transplantation receiving detailed
in-vivo and ex-vivo (explanted heart) imaging.
Methods
Consecutive patients with HCM underwent a standardized
imaging protocol using a 3-Tesla MR system. This was
inclusive of T2-weighted imaging using a short-Tau
inversion-recovery (STIR) fast spin echo sequence in serial
short axis imaging planes both with and without body
surface coils. Cine and LGE imaging was performed in
identical slice orientations. Blinded analysis of left ventri-
cular (LV) wall thickness, LV volumes, T2 signal enhance-
ment and LGE signal abnormalities were performed using
commercial software. In a patient planned for transplanta-
tion, a detailed in-vivo and ex-vivo imaging protocol was
performed, the latter performing high-resolution isotropic
T2-weighted imaging. Tissue was sampled from regions
with and without abnormal T2 signal and exposed to com-
prehensive histologic examination.
Results
A total of 83 patients were studied (mean age 54.4 ± 12.5).
T2 signal abnormalities were identified in 24 patients
(29%). As shown in Figure 1, these patients were younger,
had greater myocardial mass and maximal wall thickness,
and a greater volume of myocardial fibrosis by LGE
imaging. When present, abnormal T2 signal was reliably
embedded within regions of dense fibrosis. Ex-vivo
imaging confirmed high T2 signal and was used to guide
histologic examination, showing the presence of unusual,
large vascular channels. These were confirmed by
immuno-histochemical staining to be lymphatic in origin
(Figure 2).
Conclusions
In the largest series to date of T2-weighted imaging in
HCM, we identify that T2 signal abnormalities occur in
one-third of patients and are associated with an advanced
disease phenotype. These patients are typically younger
with more myocardial hypertrophy and fibrosis. In a
patient undergoing transplantation, T2 signal was histolo-
gically correlated to abnormal lympathic channels
embedded in dense fibrosis. The capacity of these channels
to contribute to re-entry mechanisms of arrhythmia in
patients with HCM is of particular interest.
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Figure 1 Clinical and MRI-based characteristics of hypertrophic cardiomyopathy patients with and without abnormal T2 signal.
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Figure 2 Correlation of late gadolinium enhancement and T2-weighted (T2) imaging findings and histopathology in a 52 yo male
undergoing cardiac transplantation. Region of increased T2 signal [A] demonstrates large vascular channels embedded within dense fibrosis
(arrows), staining positive for lymphatic endothelium (right panel). A reference region of fibrosis without abnormal T2 signal [B] demonstrates
only fibrosis with scant fat deposits.
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